LISA AREHART: Open Payments
NPI 1730116823 · CRITTENDEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 66 payments from 20 companies in 2025. Trend: 2023 $1,192 · 2024 $1,100 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $288 |
| Novo Nordisk Inc | 9 | $215 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $80 |
| PFIZER INC. | 4 | $70 |
| Dexcom, Inc. | 3 | $58 |
| Verona Pharma, Inc. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Lilly USA, LLC | 3 | $46 |
| Astellas Pharma US Inc | 2 | $41 |
| Lundbeck LLC | 2 | $35 |
Products named: VRAYLAR, Ozempic, CAPLYTA, UBRELVY, Dexcom G6 Transmitter, Ohtuvayre, XIFAXAN, Rybelsus.
Industry payments across KY — which companies pay providers there.
